New research published in Neuropsychopharmacology provides insight into the acute dose dependent effects of LSD.
Ionic Brands (CSE: IONC) is creating a multi-state, consumer focused, premium cannabis porfolio consisting of iconic national brands.
They have:
- Stylish products
- World Class Management Team
- A proven and repeatable strategy for success
Experienced and proven luxury cannabis concentrates brand
One of the tops selling vape brands in WA State with a loyal customer base
Largest standalone oil manufacturer in the state of WA
Consistent sales growth over 3 years with a verified marketing blueprint
Offers investors exposure to a premium luxury cannabis brand
Demonstrated to have a winning formula to become the top vape company in WA
Massive growth opportunity available with expansion into OR, NV and CA
New research published in Neuropsychopharmacology provides insight into the acute dose dependent effects of LSD.
Part of the benefit from psychedelic medicine may actually be a Placebo Effect. Find out why that is actually a GOOD thing.
A New York lawmaker is proposing to decriminalize psychedelic mushrooms in the state.
Damon Michaels, chief operating officer of emerging biotech and life sciences company Mydecine sat down with The Dales Report last week to discuss the company’s latest activity.
The newly confirmed head of the U.S. Department of Agriculture (USDA) has given final approval to a federal rule laying out regulations for the hemp industry, despite outstanding concerns from advocates about certain provisions.
New research suggests that MDMA-assisted therapy for the treatment of posttraumatic stress disorder (PTSD) is less effective among those who have recently used selective serotonin reuptake inhibitors (SSRIs), a common psychiatric medication.